{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T15:28:49Z","timestamp":1761060529677},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2018,2,26]],"date-time":"2018-02-26T00:00:00Z","timestamp":1519603200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Urologe"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1007\/s00120-018-0597-3","type":"journal-article","created":{"date-parts":[[2018,2,26]],"date-time":"2018-02-26T09:28:18Z","timestamp":1519637298000},"page":"413-417","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Humane Papillomaviren und Peniskarzinom"],"prefix":"10.1007","volume":"57","author":[{"given":"P.","family":"Schneede","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Schlenker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,2,26]]},"reference":[{"key":"597_CR1","first-page":"259","volume-title":"WHO classification of tumours of the urinary system and male genital organs","author":"AL Cubilla","year":"2016","unstructured":"Cubilla AL, Amin MB, Ayala A et\u00a0al (2016) Tumours of the penis. In: Moch H, Humphrey PA, Ulbright TM, al (Hrsg) WHO classification of tumours of the urinary system and male genital organs. IARC, Lyon, S\u00a0259\u2013286"},{"key":"597_CR2","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1097\/PAS.0b013e3181c76a49","volume":"34","author":"AL Cubilla","year":"2010","unstructured":"Cubilla AL, Lloveras B, Alejo M et\u00a0al (2010) The basaloid cell is the best tissue marker for human papillomavirus in invasive penile squamous cell carcinoma: a\u00a0study of 202 cases from Paraguay. Am J Surg Pathol 34:104\u2013114","journal-title":"Am J Surg Pathol"},{"key":"597_CR3","volume-title":"S3-Leitlinie zur Impfpr\u00e4vention HPV-assoziierter Neoplasien (AWMF-Register-Nr.: 082\/002)","author":"G Gross","year":"2013","unstructured":"Gross G, Becker N, Brockmeyer NH et al (2013) S3-Leitlinie zur Impfpr\u00e4vention HPV-assoziierter Neoplasien (AWMF-Register-Nr.: 082\/002). \n                    http:\/\/www.awmf.org\/uploads\/tx_szleitlinien\/082-002\n                    \n                  . Zugegriffen: 28. Okt. 2017"},{"key":"597_CR4","doi-asserted-by":"publisher","DOI":"10.12688\/f1000ersearch9701.1","author":"K Hellner","year":"2017","unstructured":"Hellner K, Dorrell L (2017) Recent advances in understanding and preventing human papillomavirus-related disease. F1000Res. \n                    https:\/\/doi.org\/10.12688\/f1000ersearch9701.1","journal-title":"F1000Res"},{"key":"597_CR5","unstructured":"http:\/\/www.health.gov.il\/English\/Topics\/Vaccination\/HPV\n                    \n                   . Zugegriffen: 3. Nov. 2017"},{"key":"597_CR6","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1089\/hum.2014.024","volume":"25","author":"R Rosales","year":"2014","unstructured":"Rosales R, Lopez-Contreras M, Rosales C et al (2014) Regression of human papillomavirus intraepithelial lesions is induced by MVA E2 therapeutic vaccine. Hum Gene Ther 25:1035\u20131049","journal-title":"Hum Gene Ther"},{"key":"597_CR7","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1016\/S0002-9440(10)62506-0","volume":"159","author":"MA Rubin","year":"2001","unstructured":"Rubin MA, Kleter B, Zhou M et\u00a0al (2001) Detection and typing of human papillomavirus DNA in penile carcinoma: evidence for multiple independent pathways of penile carcinogenesis. Am J Pathol 159:1211\u20131218","journal-title":"Am J Pathol"},{"key":"597_CR8","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1007\/s00120-017-0394-4","volume":"56","author":"P Schneede","year":"2017","unstructured":"Schneede P (2017) Ein Jahrzehnt der HPV-Impfung in Deutschland. Urologe 56:728\u2013733","journal-title":"Urologe"},{"key":"597_CR9","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1007\/s00120-013-3257-7","volume":"52","author":"P Schneede","year":"2013","unstructured":"Schneede P, Waidelich R (2013) Humane Papillomviren in der Urologie. Grundlagen und Kontroversen. Urologe 52:1329\u20131338","journal-title":"Urologe"},{"key":"597_CR10","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/s00105-016-3924-x","volume":"68","author":"M Spokert","year":"2017","unstructured":"Spokert M, R\u00fcbben A (2017) Buschke-Lowenstein tumors. Hautarzt 68:199\u2013203","journal-title":"Hautarzt"},{"key":"597_CR11","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1080\/14760584.2016.1176533","volume":"15","author":"P Vici","year":"2016","unstructured":"Vici P, Pizzuti L, Mariani L et\u00a0al (2016) Targeting immune response with therapeutic vaccines in premalignant lesions and cervical cancer: hope or reality from clinical studies. Expert Rev Vaccines 15:1327\u20131336","journal-title":"Expert Rev Vaccines"},{"key":"597_CR12","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1586\/14760584.2016.1157477","volume":"15","author":"A Yang","year":"2016","unstructured":"Yang A, Jeang J, Cheng K et\u00a0al (2016) Current state in the development of candidate therapeutic HPV vaccines. Expert Rev Vaccines 15:989\u20131007","journal-title":"Expert Rev Vaccines"},{"key":"597_CR13","first-page":"794","volume":"36","author":"H Hausen zur","year":"1976","unstructured":"zur Hausen H (1976) Condylomata acuminata and human genital cancer. Cancer Res 36:794","journal-title":"Cancer Res"}],"container-title":["Der Urologe"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00120-018-0597-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00120-018-0597-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00120-018-0597-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,2,25]],"date-time":"2019-02-25T20:41:06Z","timestamp":1551127266000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00120-018-0597-3"}},"subtitle":["\u00dcberlegungen zu Pr\u00e4ventionsma\u00dfnahmen"],"short-title":[],"issued":{"date-parts":[[2018,2,26]]},"references-count":13,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["597"],"URL":"https:\/\/doi.org\/10.1007\/s00120-018-0597-3","relation":{},"ISSN":["0340-2592","1433-0563"],"issn-type":[{"value":"0340-2592","type":"print"},{"value":"1433-0563","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,26]]},"assertion":[{"value":"26 February 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"P.\u00a0Schneede gibt an, als Mitglied des Arbeitskreises \u201eHPV-Management-Forum\u201c indirekt \u00fcber die Paul-Ehrlich-Gesellschaft als Referent bei HPV-Weiterbildungen sowie bei HPV-Leitlinien-Erarbeitungen von HPV-Impfstoffherstellern unterst\u00fctzt worden zu sein. B.\u00a0Schlenker gibt an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"Dieser Beitrag beinhaltet keine von den Autoren durchgef\u00fchrten Studien an Menschen oder Tieren.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics"}}]}}